SNSE (STOCKS)
Sensei Biotherapeutics, Inc. Common Stock
$30.150000
+0.260000 (+0.87%)
Prev close: $29.890000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Christopher W. Gerry
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $40.38M
- Employees
- 15
- P/E (TTM)
- -1.57
- P/B (TTM)
- 2.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $22.29M |
| Operating Income/Loss | -$22.29M |
| Income/Loss From Continuing Operations After Tax | -$18.47M |
| Income/Loss From Continuing Operations Before Tax | -$21.09M |
| Income Tax Expense/Benefit | -$2.62M |
| Income Tax Expense/Benefit, Deferred | -$2.62M |
| Interest Expense, Operating | $32.00K |
| Net Income/Loss | -$21.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$21.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$16.72 |
| Diluted Earnings Per Share | -$16.72 |
| Basic Average Shares | 1,260,772 |
| Diluted Average Shares | 1,260,772 |
| Assets | $22.90M |
| Current Assets | $21.51M |
| Prepaid Expenses | $231.00K |
| Other Current Assets | $21.28M |
| Noncurrent Assets | $1.40M |
| Fixed Assets | $82.00K |
| Other Non-current Assets | $1.31M |
| Liabilities | $4.31M |
| Current Liabilities | $4.25M |
| Accounts Payable | $689.00K |
| Wages | $1.32M |
| Other Current Liabilities | $2.24M |
| Noncurrent Liabilities | $59.00K |
| Equity | $18.59M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $18.59M |
| Liabilities And Equity | $22.90M |
| Net Cash Flow From Operating Activities | -$20.45M |
| Net Cash Flow From Operating Activities, Continuing | -$20.45M |
| Net Cash Flow From Investing Activities | $19.77M |
| Net Cash Flow From Investing Activities, Continuing | $19.77M |
| Net Cash Flow From Financing Activities | -$645.00K |
| Net Cash Flow From Financing Activities, Continuing | -$645.00K |
| Net Cash Flow | -$1.33M |
| Net Cash Flow, Continuing | -$1.33M |
| Comprehensive Income/Loss | -$21.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$21.07M |
| Other Comprehensive Income/Loss | $14.00K |